JPH0558407B2 - - Google Patents

Info

Publication number
JPH0558407B2
JPH0558407B2 JP60120328A JP12032885A JPH0558407B2 JP H0558407 B2 JPH0558407 B2 JP H0558407B2 JP 60120328 A JP60120328 A JP 60120328A JP 12032885 A JP12032885 A JP 12032885A JP H0558407 B2 JPH0558407 B2 JP H0558407B2
Authority
JP
Japan
Prior art keywords
acid
bath
oil
tablets
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60120328A
Other languages
Japanese (ja)
Other versions
JPS61277611A (en
Inventor
Hidenori Yorozu
Yasuteru Eguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP60120328A priority Critical patent/JPS61277611A/en
Publication of JPS61277611A publication Critical patent/JPS61277611A/en
Publication of JPH0558407B2 publication Critical patent/JPH0558407B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22Gas releasing
    • A61K2800/222Effervescent

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 本発明は新規な弱酸性入浴剤、更に詳細には、
炭酸塩と酸を含有し、使用時の浴湯PHが弱酸性を
呈する入浴剤に生薬抽出物を安定に配合すること
により、血行促進効果及び肌のしつとり感を相乗
的に高めた弱酸性入浴剤に関する。 〔従来の技術〕 炭酸塩と酸を含有し、浴湯のPHが弱酸性を呈す
る入浴剤は、発生する炭酸ガスが溶液中に留まる
ことにより優れた血行促進作用を示すことが知ら
れている。そして本発明者らは、その浴用効果を
高めるべく、これに生薬を配合した弱酸性入浴剤
を開発した(特願昭59−73507号)。 〔発明が解決しようとする問題点〕 しかしながら、錠剤としてこの生薬を配合した
弱酸性入浴剤を実用化するとき、(1)生薬をそのま
ま配合した場合には、生薬由来の不溶物が浴湯中
にただよい不快感を生ずる、(2)生薬抽出物を用い
た場合は、錠剤中で該抽出物が酸・アルカリの混
合系という過酷な条件下におかれるため、使用時
までに生薬有効成分が分解するなどして効果が低
下したり、異臭が発生する等の欠点があつた。 〔問題点を解決するための手段〕 そこで、本発明者らは斯様な欠点を解消すべく
鋭意研究を行つた結果、生薬抽出物を吸収又は吸
着した吸油剤を顆粒又は錠剤状にし、これを核と
して用いることにより、これらの欠点が悉く解消
されることを見い出し、本発明を完成した。 すなわち、本発明は、生薬抽出物を吸収又は吸
着した吸油剤を顆粒又は錠剤状にし、これを核と
して炭酸塩及び酸を含有する発泡成分中に混入し
て打錠することを特徴とする弱酸性入浴剤を提供
するものである。 本発明の弱酸性入浴剤に配合される炭酸塩とし
ては、例えば炭酸水素ナトリウム、炭酸ナトリウ
ム、セスキ炭酸ナトリウム、炭酸水素カリウム、
炭酸カリウム、セスキ炭酸カリウム、炭酸水素ア
ンモニウム塩、炭酸アンモニウム塩、セスキ炭酸
アンモニウム塩等が挙げられ、これらは単独又は
2種以上を組合わせて使用できる。 また、酸としては、有機酸及び無機酸の何れも
使用できるが、水溶性で固体のものが好ましい。
有機酸としては、例えばギ酸、酢酸、プロピオン
酸、酪酸、吉草酸等の直鎖脂肪酸;シユウ酸、マ
ロン酸、コハク酸、グルタル酸、アジピン酸、ピ
メリン酸、フマル酸、マレイン酸、フタル酸、イ
ソフタル酸、テレフタル酸等のジカルボン酸;グ
ルタミン酸、アスパラギン酸等の酸性アミノ酸;
グリコール酸、乳酸、ヒドロキシアクリル酸、α
−オキシ酪酸、グリセリン酸、タルトロン酸、リ
ンゴ酸、酒石酸、クエン酸、サリチル酸(o、
m、p)、没食子酸、マンデル酸、トロパ酸、ア
スコルビン酸、グルコン酸等のオキシ酸;桂皮
酸、安息香酸、フエニル酢酸、ニコチン酸、カイ
ニン酸、ソルビン酸、ピロリドンカルボン酸、ト
リメリツト酸、ベンゼンスルホン酸、トルエンス
ルホン酸並びにこれら有機酸の酸性塩が挙げられ
る。無機酸としては、例えば、リン酸、リン酸二
水素カリウム、リン酸二水素ナトリウム、亜硫酸
ナトリウム、亜硫酸カリウム、ピロ亜硫酸ナトリ
ウム(メタ重亜硫酸ナトリウム)、ピロ亜硫酸カ
リウム(メタ重亜硫酸カリウム)、酸性ヘキサメ
タリン酸ナトリウム、酸性ヘキサメタリン酸カリ
ウム、酸性ピロリン酸ナトリウム、酸性ピロリン
酸カリウム、スルフアミン酸等が挙げられる。就
中、コハク酸、アジピン酸等の脂肪族ジカルボン
酸、フマル酸、リン酸及びこれらの酸性塩が好ま
しい。 生薬抽出物は特に制限されないが、例えば、ソ
ウジユツ、ビヤクジユツ、カノコソウ、ケイガ
イ、コウボク、センキユウ、トウヒ、トウキ、シ
ヨウキヨウ、シヤクヤク、オウバク、オウゴン、
サンシシ、ケイヒ、ニンジン、ブクリヨウ、トク
ガク、シヨウブ、ガイヨウ、マツブサ、ビヤク
シ、ジユウヤク、ウイキヨウ、チンピ、カンピ、
カミツレ等の生薬からの抽出物が挙げられる。こ
れら生薬は一種又は二種以上の混合物としても使
用することができる。 これらの生薬抽出物としては、上記生薬を水;
エタノール、イソプロパノール等の低級アルコー
ル;大豆油、胡麻油、オリーブ油等の植物油;肝
油、ミンク油、鯨油等の動物油;流動パラフイ
ン、ワセリン等の鉱物;ミリスチン酸イソプロピ
ル、オレイル酸デシルエステル等のエステル油;
多価アルコール化合物等の溶剤又はこれらの2種
以上の混合溶剤で抽出する方法、あるいは炭酸ガ
ス等のガスで抽出する方法等によつて得られる抽
出エキス又は抽出物が挙げられる。就中、水又は
水/アルコールによつて抽出されたものが特に好
ましい。 また、吸油剤としては、上記生薬抽出物の油成
分を吸収、吸着して安定に保持する能力を有する
ものであればよく、例えばデンプン、デキストリ
ン、シクロデキストリン等の天然物;シリカ、ケ
イ酸カルシウム等のケイ酸塩;粘土鉱物、パーラ
イト、カーボンブラツク、ポリウレタン系高分
子、ポリオレフイン系高分子等が挙げられる。こ
れらの吸油剤は、油保持能力が1.5ml/g以上、
特に3ml/g以上のものが好ましい。吸油剤の使
用量は、その種類によつても異なるが、生薬抽出
物の50〜500重量%(以下単に%で示す)が好ま
しい。 本発明の弱酸性入浴剤中の生薬抽出物を充分安
定に保つためには、生薬抽出物を吸収又は吸着し
た吸油剤を顆粒若しくは錠剤状にし(就中、錠剤
状が好ましい)、これを核として炭酸塩及び酸か
らなる発泡成分中に混入して打錠した有核錠剤弱
酸性入浴剤とする必要がある。 この核の形成には、一般に、ソルビツト、マン
ニツト等の糖類;ポリアクリル酸ナトリウム、カ
ルボキシメチルセルロース等の水溶性高分子等の
通常使用されている賦形剤を用いるのが好まし
い。この賦形剤の量は生薬抽出物の20〜500%が
好ましい。 これら顆粒若しくは錠剤状の核は、更に水溶性
高分子状物質で被覆することにより一層の効果が
得られる。 水溶性高分子状物質としては、ヒドロキシエチ
ルセルロース(HEC)、ヒドロキシプロピルセル
ロース(HPC)、ヒドロキシプロピルメチルセル
ロース(HPMC)、ポリエチレングリコール
(PEG)等の水溶性コーテイング剤が好ましい。 本発明弱酸性入浴剤の炭酸塩と酸の配合量は、
入浴剤を浴湯に加えたとき浴湯が弱酸性を呈する
ような比率、すなわち入浴剤の0.01%水溶液がPH
4〜7、特に好ましくはPH6.0〜6.7になるように
することが必要である。PHが4より低いと肌への
刺激が強いと共に風呂釜等をいためる惧れがあ
り、またPHが7を超えると本発明の効果が奏され
ない。 本発明の効果は、PHが酸性の場合には炭酸ガス
はCO2分子として存在して血流促進作用を示す
が、PHがアルカリ性側では炭酸ガスはCO2- 3イオ
ンあるいはHCO- 3イオンとして存在するため当該
効果は全く見られないという原理に基くものであ
る。 斯かる条件を具備するための炭酸塩と酸の配合
量は、これらの種類によつて異なるが、全組成に
対し、炭酸塩は5〜80%特に10〜50%、酸は10〜
80%、特に15〜50%が好ましい。 また、生薬抽出物は、広い範囲の量で配合でき
るが、全組成に対し0.01〜20%、特に0.1〜10%
が好ましい。 更に、本発明入浴剤には、一般に配合されてい
る香料、色素あるいはビタミン類、温泉の有効成
分、酵素、海草エキス、ラノリン、シリコン等を
核部分中、もしくは外殻部分中に配合することが
できる。また製剤化のために必要に応じて賦形
剤、結合剤、崩壊剤、滑沢剤等を添加することも
できる。 〔作用及び発明の効果〕 叙上の如く、本発明の弱酸性入浴剤はPHが人の
肌と大略同一であるので肌に好影響を与える。し
かも浴湯に投ずるとき発生する炭酸ガスは、アル
カリ性ではイオンとして存在するため血流促進効
果はないが、本発明の如く酸性領域ではCO2分子
として存在して肌の血行を促進する優れた効果を
奏する。更にまた、生薬成分の分解による異臭を
発することなく安定に配合された生薬抽出物との
相乗作用で血行促進、保温、肌のしつとり感等す
ぐれた浴用効果を示す。 〔実施例〕 次に実施例を挙げて本発明を詳細に説明する。 実施例 1 センキユウエキス20%とデキストリン75%を混
合し粉末化したものに芒硝3.5%、アビセル1.5%
を混合し、打錠して1錠5gの錠剤(核部分)を
得る。 この錠剤を核部分として、外殻成分が重炭酸ナ
トリウム30%、炭酸ナトリウム15%、コハク酸40
%、芒硝15%、色素微量からなる混合物を打錠
し、1錠50gの錠剤を製造した。これをアルミ製
のフイルムに包装し製品とした。 実施例 2 センキユウエキスをトウキエキスに変えた以外
は実施例1と同様にして1錠50gの入浴剤を製造
した。 実施例 3 センキユウエキスをチンピエキスに変えた以外
は実施例1と同様にして1錠50gの入浴剤を製造
した。 比較例 1 実施例1において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。 比較例 2 実施例2において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。 比較例 3 実施例3において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。 実施例 4 本発明入浴剤の血流量及び皮膚表面温度に対す
る作用を以下の如くして検討した。 <方法> 被験者者8名を対象として、更湯、比較例1の
浴剤添加浴又は本発明による実施例1浴剤添加浴
に10分間入浴させ、入浴前後の各種測定を行つ
た。なお、湯温は40℃、室温25℃であり、入浴剤
は、0.02%溶液となるように希釈して用いた。 測定は、血流計についてはレーザードツプラー
血流計を皮膚表面温度については赤外線温度計を
用いた。 <結果> 測定結果は、表1(血流量)及び表2(皮膚表面
温度)に示した。なお、数値は8名の平均値で示
した。 表1、表2から明らかなように、本発明品が優
れた血行促進効果、保温効果を示すことがわか
る。
[Industrial Application Field] The present invention provides a novel weakly acidic bath additive, more specifically,
By stably blending crude drug extracts into bath additives that contain carbonates and acids, and which have a slightly acidic bath water PH when used, a mild bath additive that synergistically enhances the blood circulation promoting effect and the moisturizing feeling of the skin. Regarding acidic bath additives. [Prior Art] It is known that bath additives that contain carbonate and acid and have a slightly acidic PH of the bath water exhibit excellent blood circulation promoting effects because the carbon dioxide gas generated remains in the solution. . In order to enhance the bathing effect, the present inventors have developed a weakly acidic bath additive containing herbal medicine (Japanese Patent Application No. 73507/1982). [Problems to be solved by the invention] However, when putting into practical use a weakly acidic bath additive containing this crude drug in the form of tablets, (1) If the crude drug is blended as is, insoluble substances derived from the crude drug may be mixed into the bath water. (2) When extracts of herbal medicines are used, the extracts are placed in the harsh conditions of a mixture of acid and alkali in the tablets, so the active ingredients of the herbal medicines are removed by the time of use. However, there were drawbacks such as decomposition, resulting in decreased effectiveness, and the generation of strange odors. [Means for Solving the Problems] Therefore, the present inventors conducted intensive research in order to eliminate such drawbacks, and as a result, they made oil-absorbing agents that absorbed or adsorbed crude drug extracts into granules or tablets. The present invention was completed based on the discovery that all of these drawbacks can be overcome by using the following as a core. That is, the present invention is characterized in that an oil-absorbing agent that has absorbed or adsorbed a herbal medicine extract is made into granules or tablets, and the granules or tablets are mixed into a foaming component containing a carbonate and an acid to form a tablet. It provides acidic bath salts. Examples of carbonates to be added to the weakly acidic bath additives of the present invention include sodium hydrogen carbonate, sodium carbonate, sodium sesquicarbonate, potassium hydrogen carbonate,
Potassium carbonate, potassium sesquicarbonate, ammonium bicarbonate salt, ammonium carbonate salt, ammonium sesquicarbonate salt, etc. are mentioned, and these can be used alone or in combination of two or more kinds. Further, as the acid, both organic acids and inorganic acids can be used, but water-soluble and solid acids are preferred.
Examples of organic acids include straight chain fatty acids such as formic acid, acetic acid, propionic acid, butyric acid, and valeric acid; oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid, phthalic acid, Dicarboxylic acids such as isophthalic acid and terephthalic acid; acidic amino acids such as glutamic acid and aspartic acid;
Glycolic acid, lactic acid, hydroxyacrylic acid, α
-oxybutyric acid, glyceric acid, tartronic acid, malic acid, tartaric acid, citric acid, salicylic acid (o,
m, p), oxyacids such as gallic acid, mandelic acid, tropic acid, ascorbic acid, gluconic acid; cinnamic acid, benzoic acid, phenylacetic acid, nicotinic acid, kainic acid, sorbic acid, pyrrolidonecarboxylic acid, trimellitic acid, benzene Examples include sulfonic acid, toluenesulfonic acid, and acid salts of these organic acids. Examples of inorganic acids include phosphoric acid, potassium dihydrogen phosphate, sodium dihydrogen phosphate, sodium sulfite, potassium sulfite, sodium pyrosulfite (sodium metabisulfite), potassium pyrosulfite (potassium metabisulfite), and acidic hexamethaline. Examples include sodium acid, potassium acid hexametaphosphate, sodium acid pyrophosphate, potassium acid pyrophosphate, and sulfamic acid. Among these, aliphatic dicarboxylic acids such as succinic acid and adipic acid, fumaric acid, phosphoric acid, and acid salts thereof are preferred. Herbal medicine extracts are not particularly limited, but include, for example, Soujiyutsu, Biyakujiyutsu, Valerian, Keigai, Kobokou, Senkiyu, Spruce, Equilibrium, Aspergillus japonica, Syakuyaku, Aspergillus japonica, Aspergillus scutellariae,
Sanshishi, Keihi, Carrot, Bukuriyo, Tokugaku, Shobu, Gaiyo, Matsubusa, Byakushi, Jiyuyaku, Uikiyo, Chimpi, Campi,
Examples include extracts from herbal medicines such as chamomile. These crude drugs can be used alone or as a mixture of two or more. These herbal medicine extracts include the above herbal medicines in water;
Lower alcohols such as ethanol and isopropanol; Vegetable oils such as soybean oil, sesame oil, and olive oil; Animal oils such as cod liver oil, mink oil, and whale oil; Minerals such as liquid paraffin and petrolatum; Ester oils such as isopropyl myristate and decyl oleate;
Examples include extracts obtained by a method of extraction with a solvent such as a polyhydric alcohol compound or a mixed solvent of two or more thereof, or a method of extraction with a gas such as carbon dioxide gas. Among these, those extracted with water or water/alcohol are particularly preferred. In addition, the oil-absorbing agent may be one that has the ability to absorb, adsorb, and stably retain the oil component of the herbal medicine extract, such as natural products such as starch, dextrin, and cyclodextrin; silica, and calcium silicate. silicates such as clay minerals, pearlite, carbon black, polyurethane polymers, polyolefin polymers, etc. These oil absorbers have an oil retention capacity of 1.5ml/g or more,
Particularly preferred is 3 ml/g or more. The amount of the oil-absorbing agent used varies depending on its type, but is preferably 50 to 500% by weight of the herbal medicine extract (hereinafter simply expressed as %). In order to keep the herbal medicine extracts in the weakly acidic bath additives of the present invention sufficiently stable, the oil-absorbing agent that has absorbed or adsorbed the herbal medicine extracts is made into granules or tablets (particularly tablets are preferred), and the oil absorbent is made into granules or tablets. Therefore, it is necessary to prepare a weakly acidic bath salt in the form of a dry-coated tablet, which is mixed into an effervescent component consisting of a carbonate and an acid and then compressed into a tablet. For the formation of this core, it is generally preferable to use commonly used excipients such as saccharides such as sorbitate and mannite; water-soluble polymers such as sodium polyacrylate and carboxymethyl cellulose. The amount of this excipient is preferably 20-500% of the crude drug extract. Further effects can be obtained by coating these granule or tablet cores with a water-soluble polymeric substance. As the water-soluble polymeric substance, water-soluble coating agents such as hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), hydroxypropyl methyl cellulose (HPMC), and polyethylene glycol (PEG) are preferred. The amount of carbonate and acid in the weakly acidic bath additive of the present invention is as follows:
When bath additives are added to bath water, the ratio is such that the bath water becomes slightly acidic, that is, the PH of a 0.01% aqueous solution of bath additives is
It is necessary to adjust the pH to 4 to 7, particularly preferably 6.0 to 6.7. If the pH is lower than 4, there is a risk of strong skin irritation and damage to the bathtub, etc. If the pH is higher than 7, the effects of the present invention will not be achieved. The effect of the present invention is that when the pH is acidic, carbon dioxide gas exists as CO 2 molecules and exhibits a blood flow promoting effect, but when the pH is alkaline, carbon dioxide gas exists as CO 2-3 ions or HCO - 3 ions . This is based on the principle that the effect is not observed at all because the The blending amounts of carbonate and acid to meet these conditions vary depending on their type, but carbonate should be 5 to 80%, particularly 10 to 50%, and acid should be 10 to 50% of the total composition.
80%, especially 15-50% is preferred. In addition, crude drug extracts can be added in a wide range of amounts, but 0.01 to 20%, especially 0.1 to 10% of the total composition.
is preferred. Furthermore, the bath salts of the present invention may contain commonly-used fragrances, pigments, vitamins, hot spring active ingredients, enzymes, seaweed extracts, lanolin, silicone, etc. in the core or outer shell. can. Further, excipients, binders, disintegrants, lubricants, etc. may be added as necessary for formulation. [Operation and Effects of the Invention] As mentioned above, the weakly acidic bath additive of the present invention has a favorable effect on the skin since its pH is approximately the same as that of human skin. Moreover, the carbon dioxide gas generated when pouring into bath water exists as ions in alkaline conditions and has no effect of promoting blood flow, but in acidic conditions as in the present invention, it exists as CO 2 molecules and has an excellent effect of promoting blood circulation in the skin. play. Furthermore, the synergistic effect with the stably blended herbal medicine extract without emitting any off-odor due to the decomposition of the herbal medicine ingredients provides excellent bathing effects such as promotion of blood circulation, heat retention, and a moisturizing feeling on the skin. [Example] Next, the present invention will be explained in detail with reference to Examples. Example 1 Powdered mixture of 20% Senkiyu extract and 75% dextrin, 3.5% Glauber's salt, 1.5% Avicel
Mix and tablet to obtain 5 g tablets (core portion). With this tablet as the core, the outer shell components are 30% sodium bicarbonate, 15% sodium carbonate, and 40% succinic acid.
%, 15% Glauber's Salt, and a trace amount of pigment were compressed into tablets each weighing 50 g. This was packaged in an aluminum film and made into a product. Example 2 A bath salt weighing 50 g per tablet was produced in the same manner as in Example 1, except that the extract was replaced with the Angelica extract. Example 3 A bath salt weighing 50 g per tablet was produced in the same manner as in Example 1, except that the extract was replaced with the extract of the chinpiper. Comparative Example 1 In Example 1, a bath salt of 50 g per tablet was produced by simply mixing and tableting the core part and the outer shell part without making small tablets. Comparative Example 2 In Example 2, a bath additive of 50 g per tablet was produced by simply mixing and tableting the core portion and the outer shell portion without making small tablets. Comparative Example 3 In Example 3, a bath salt of 50 g per tablet was produced by simply mixing and tableting the core part with the outer shell part without making small tablets. Example 4 The effect of the bath additive of the present invention on blood flow and skin surface temperature was investigated as follows. <Method> Eight subjects were allowed to take a bath for 10 minutes in a hot bath, a bath with added bath additives in Comparative Example 1, or a bath with added bath agents in Example 1 according to the present invention, and various measurements were taken before and after taking the bath. The water temperature was 40°C and the room temperature was 25°C, and the bath additives were diluted to a 0.02% solution. For measurement, a laser Doppler blood flow meter was used for the blood flow meter, and an infrared thermometer was used for the skin surface temperature. <Results> The measurement results are shown in Table 1 (blood flow) and Table 2 (skin surface temperature). In addition, the numerical value was shown as the average value of 8 people. As is clear from Tables 1 and 2, it can be seen that the products of the present invention exhibit excellent blood circulation promoting effects and heat retention effects.

【表】 たときの相対値を示した。
[Table] Shows relative values when

【表】 実施例 5 実施例1〜3、比較例1〜3の入浴剤を調製
し、各入浴剤を0.03%溶液になるように浴湯に投
入し、パネラー10名に1ケ月間常法に従つて使用
してもらい、入浴剤としての全体評価(総合的な
使用感)、あたたまり感、湯冷めの有無及び肌の
しつとり感を調べた。その結果を表3に示す。い
ずれも実施例がすぐれていることがわかる。
[Table] Example 5 The bath additives of Examples 1 to 3 and Comparative Examples 1 to 3 were prepared, each bath additive was added to bath water to make a 0.03% solution, and 10 panelists were given a standard method for one month. The bath additives were used according to the instructions, and the overall evaluation (overall feeling of use) as a bath additive, the feeling of warmth, whether or not the water cooled, and the feeling of moisturizing the skin were evaluated. The results are shown in Table 3. It can be seen that the examples are excellent in all cases.

【表】【table】

Claims (1)

【特許請求の範囲】[Claims] 1 生薬抽出物を吸収又は吸着した吸油剤を顆粒
又は錠剤状にし、これを核として炭酸塩及び酸を
含有する発泡成分中に混入して打錠することを特
徴とする弱酸性入浴剤。
1. A weakly acidic bath additive characterized by granulating or tableting an oil-absorbing agent that has absorbed or adsorbed crude drug extracts, and mixing the granules or tablets as a core into a foaming component containing carbonate and acid to form a tablet.
JP60120328A 1985-06-03 1985-06-03 Weakly acidic bathing agent Granted JPS61277611A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60120328A JPS61277611A (en) 1985-06-03 1985-06-03 Weakly acidic bathing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60120328A JPS61277611A (en) 1985-06-03 1985-06-03 Weakly acidic bathing agent

Publications (2)

Publication Number Publication Date
JPS61277611A JPS61277611A (en) 1986-12-08
JPH0558407B2 true JPH0558407B2 (en) 1993-08-26

Family

ID=14783536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60120328A Granted JPS61277611A (en) 1985-06-03 1985-06-03 Weakly acidic bathing agent

Country Status (1)

Country Link
JP (1) JPS61277611A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172319A (en) * 1987-12-25 1989-07-07 Nissan Setsuken Kk Effervescent bathing agent composition
JP2544297B2 (en) * 1993-08-27 1996-10-16 花王株式会社 Effervescent tablet type bath agent containing capsules
CN100412182C (en) * 2003-12-03 2008-08-20 吴广权 Bathing bead and method for preparing the same
JP2014210734A (en) * 2013-04-19 2014-11-13 クラシエホームプロダクツ株式会社 Acidic bath composition
US20180369095A1 (en) 2015-12-21 2018-12-27 L'oreal Cosmetic composition comprising a specific filler combination and a film-forming polymer to increase long-lasting effects

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5432616A (en) * 1977-08-17 1979-03-10 Tsumura Juntendo Kk Bathing agent
JPS5970609A (en) * 1982-10-14 1984-04-21 Kao Corp Weakly acidic bathing agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5432616A (en) * 1977-08-17 1979-03-10 Tsumura Juntendo Kk Bathing agent
JPS5970609A (en) * 1982-10-14 1984-04-21 Kao Corp Weakly acidic bathing agent

Also Published As

Publication number Publication date
JPS61277611A (en) 1986-12-08

Similar Documents

Publication Publication Date Title
KR940007919B1 (en) Weakly acidic bath salt composition
US5955057A (en) Effervescing or foaming bath shape or solid
DE69224024T2 (en) TORF-DERIVATED BIOACTIVE PRODUCTS AND THEIR CONTAINING PHARMACEUTICAL AND COSMETIC COMPOSITIONS
JP2000229841A (en) Mixed type bath preparation
JPH0558407B2 (en)
JP2622574B2 (en) Bath additive
JP2523311B2 (en) Bath agent
JP2544102B2 (en) Weakly acidic bath salt
JPS61225117A (en) Weakly acidic bathing agent
JPS60215617A (en) Weak-acidity bath preparation
JP3535985B2 (en) Cosmetic pack and method for producing the same
JPH0334919A (en) Bathing agent
JPS60215618A (en) Weak-acidity bath preparation
JP2765675B2 (en) Granular cosmetic
JP2973368B2 (en) Bath composition
JPS60215613A (en) Weak-acidity bath preparation
JP4197084B2 (en) Bath cosmetics
JPH0717850A (en) Bathing composition
JP3340943B2 (en) Bath composition
JPS632927B2 (en)
JPH1160468A (en) Composition for bathing
JP2001226253A (en) Bathing agent
JP2613862B2 (en) Bath composition
JP2004010543A (en) Granule used as turbidity-forming agent, method for producing the same, and bath agent composition containing the granule
JPH08766B2 (en) Weakly acidic bath salt

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term